G&E Herbal Biotechnology. 

TWD27.75
0
-TWD1.45-4.97% 05:30 Today

Statistics

Day High
29.1
Day Low
27.5
52W High
46.48
52W Low
26.1
Volume
121,623
Avg. Volume
21,215
Mkt Cap
1.77B
P/E Ratio
-
Dividend Yield
3.99%
Dividend
1.11

Upcoming

Dividends

3.99%Dividend Yield
Aug 2026
TWD1.17
Aug 2025
TWD0.70
Sep 2024
TWD0.53
Sep 2015
TWD0.10
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
66.38%

Financials

40.98%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
498.07MRevenue
204.13MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
Show More
CEO
Kou-Wha Kou
Employees
38
Country
China
ISIN
TW0004911003

Listings

0 Comments

Share your thoughts

FAQs

What is G&E Herbal Biotechnology. stock price today?▼
The current price of 4911.TWO is TWD27.75 TWD — it has decreased by -4.97% in the past 24 hours. Watch G&E Herbal Biotechnology. stock price performance more closely on the chart.
What is G&E Herbal Biotechnology. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange G&E Herbal Biotechnology. stocks are traded under the ticker 4911.TWO.
Is G&E Herbal Biotechnology. stock price growing?▼
4911.TWO stock has risen by +2.78% compared to the previous week, the month change is a -2.29% fall, over the last year G&E Herbal Biotechnology. has showed a -43.08% decrease.
What is G&E Herbal Biotechnology. market cap?▼
Today G&E Herbal Biotechnology. has the market capitalization of 1.77B
What is G&E Herbal Biotechnology. revenue for the last year?▼
G&E Herbal Biotechnology. revenue for the last year amounts to 498.07M TWD.
What is G&E Herbal Biotechnology. net income for the last year?▼
4911.TWO net income for the last year is 204.13M TWD.
Does G&E Herbal Biotechnology. pay dividends?▼
Yes, 4911.TWO dividends are paid annual. The last dividend per share was 1.17 . As of today, Dividend Yield (FWD)% is 3.99%.
How many employees does G&E Herbal Biotechnology. have?▼
As of November 3, 2026, the company has 38 employees.
In which sector is G&E Herbal Biotechnology. located?▼
G&E Herbal Biotechnology. operates in the Health & Wellness sector.
When did G&E Herbal Biotechnology. complete a stock split?▼
The last stock split for G&E Herbal Biotechnology. was on July 29, 2025 with a ratio of 1080:1000.
Where is G&E Herbal Biotechnology. headquartered?▼
G&E Herbal Biotechnology. is headquartered in Tainan City, China.